[HTML][HTML] Predicting conversion to Alzheimer's disease in individuals with Mild Cognitive Impairment using clinically transferable features

I Rye, A Vik, M Kocinski, AS Lundervold… - Scientific Reports, 2022 - nature.com
Abstract Patients with Mild Cognitive Impairment (MCI) have an increased risk of Alzheimer's
disease (AD). Early identification of underlying neurodegenerative processes is essential to …

[HTML][HTML] Predicting conversion to Alzheimer's disease in individuals with Mild Cognitive Impairment using clinically transferable features

I Rye, A Vik, M Kocinski, AS Lundervold… - Scientific …, 2022 - ncbi.nlm.nih.gov
Abstract Patients with Mild Cognitive Impairment (MCI) have an increased risk of Alzheimer's
disease (AD). Early identification of underlying neurodegenerative processes is essential to …

Predicting conversion to Alzheimer's Disease in individuals with Mild Cognitive Impairment using clinically transferable features

I Rye, A Vik, M Kocinski, AS Lundervold, AJ Lundervold - 2022 - researchsquare.com
Abstract Patients with Mild Cognitive Impairment (MCI) have an increased risk of Alzheimer's
disease (AD). Early identification of underlying neurodegenerative processes is essential to …

Predicting conversion to Alzheimer's disease in individuals with Mild Cognitive Impairment using clinically transferable features

I Rye, A Vik, MM Kocinski, AS Lundervold… - 2022 - hvlopen.brage.unit.no
Patients with Mild Cognitive Impairment (MCI) have an increased risk of Alzheimer's disease
(AD). Early identification of underlying neurodegenerative processes is essential to provide …

Predicting conversion to Alzheimer's disease in individuals with Mild Cognitive Impairment using clinically transferable features.

I Rye, A Vik, M Kocinski, AS Lundervold… - Scientific …, 2022 - search.ebscohost.com
Abstract Patients with Mild Cognitive Impairment (MCI) have an increased risk of Alzheimer's
disease (AD). Early identification of underlying neurodegenerative processes is essential to …

Predicting conversion to Alzheimer's disease in individuals with Mild Cognitive Impairment using clinically transferable features

I Rye, A Vik, M Kocinski, A Lundervold - Scientific Reports, 2022 - europepmc.org
Abstract Patients with Mild Cognitive Impairment (MCI) have an increased risk of Alzheimer's
disease (AD). Early identification of underlying neurodegenerative processes is essential to …

Predicting conversion to Alzheimer's disease in individuals with Mild Cognitive Impairment using clinically transferable features

I Rye, A Vik, M Kocinski, AS Lundervold… - Scientific …, 2022 - ui.adsabs.harvard.edu
Abstract Patients with Mild Cognitive Impairment (MCI) have an increased risk of Alzheimer's
disease (AD). Early identification of underlying neurodegenerative processes is essential to …

[PDF][PDF] Predicting conversion to Alzheimer's Disease in individuals with Mild Cognitive Impairment using clinically transferable features

I Rye, A Vik, M Kocinski, AS Lundervold, AJ Lundervold - scholar.archive.org
ABSTRACT Patients with Mild Cognitive Impairment (MCI) have an increased risk of
Alzheimer's disease (AD). Early identification of underlying neurodegenerative processes is …

Predicting conversion to Alzheimer's disease in individuals with Mild Cognitive Impairment using clinically transferable features

I Rye, A Vik, MM Kocinski, AS Lundervold… - 2022 - bora.uib.no
Patients with Mild Cognitive Impairment (MCI) have an increased risk of Alzheimer's disease
(AD). Early identification of underlying neurodegenerative processes is essential to provide …

Predicting conversion to Alzheimer's disease in individuals with Mild Cognitive Impairment using clinically transferable features

I Rye, A Vik, M Kocinski, AS Lundervold… - Scientific …, 2022 - pubmed.ncbi.nlm.nih.gov
Patients with Mild Cognitive Impairment (MCI) have an increased risk of Alzheimer's disease
(AD). Early identification of underlying neurodegenerative processes is essential to provide …